⇐ A French biotech company headquartered in
⇐ Manufacturing sites in Livingston, Scotland and
Solna, Sweden and Vienna, Austria.
⇐ Produce inactivated vaccine for Lyme disease,
Chikungunya, Japanese Encephalitis, Cholera and
⇐ Successfully Phase 3 clinical trial for CPG 1018
Adjuvanted Covid-19 Vaccine (VLA2001).
⇐ Waiting approval from UK and Europe on vaccine
⇒ Swedish international pharma process
⇒ Vast experience in end to end design solution for
⇒ DCVMN vaccines manufacturing facilities auditor
(funded by GAVI).
⇒ Successfully provide pharmaceutical engineering
expertise for over 20 years.
⇒Global experience in constructing more than 100
vaccines manufacturing facilities.